After the long‐term use of platinum drugs in patients with ovarian cancer, lung cancer and colon cancer, the ABCC2 gene is often upregulated in some parts of these patients and upregulation of the ABCC2 gene usually causes patients to develop resistance to platinum drugs.23, 24. This evidence concerns the gene ABCC2 and ovarian carcinoma.